AstraZeneca 'magic' faces rare test after trial failure, share slide - Reuters
AstraZeneca 'magic' faces rare test after trial failure, share slide Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPR0g4ZlpxNDdMMDVHcV9Ka1BjMTJRZkFPVkQ0eGxUaXJzSmJQU2NEM2pLX3Y4bERtcTg4M2tjemFvYWtuWlZvdzhRRGlPMThvY2JMU1h3UkR4b3VQUEZaaEFEbkFEb3k0aTN6ajloU3hkLXpYUFVJQ0o5RDVOeE03UUhCSnBmMkJOSC01VUwyOG5yT0NpMmVBRk02NkNRMnhCajlYb0RYb0k2RVI4bmVwNzNXWnhFMkxqYU54SEdCQUZGcnZvV3NFaVRRTS1MR0tIZXk4?oc=5" target="_blank">AstraZeneca 'magic' faces rare test after trial failure, share slide</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMModerna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PMVIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
August 19, 2026 at 02:45 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PM